PLAUR and neoplasm: These approaches capitalize on the specific characteristics of cancer cells, such as the overexpression of uPAR and the presence of cancer-associated antigens like GPC3, to enable precise and efficient tumor targeting, opening up new avenues for more effective and personalized cancer treatments.